Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int Angiol ; 22(1): 55-7, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12771857

ABSTRACT

AIM: The G20210A mutation of the prothrombin gene is a genetic risk factor for venous thromboembolism (VTE). Variability exists in the mutation prevalence in both normal individuals and VTE patients. The aim of this study was to determine the mutation prevalence in Northwestern Greece and evaluate its association with VTE. METHODS: Presence of the G20210A mutation was investigated using DNA analysis in 176 consecutive patients with a history of venous thrombosis or pulmonary embolism and in 300 healthy controls, all Caucasian residents of Northwestern Greece. RESULTS: The mutation was present 12 patients (6.8%) and 8 controls (2.7%). The odds ratio for presence of the mutation versus the normal genotype in VTE was 2.7 (95% CI: 1.1 to 6.7), which was statistically significant. The prevalence of the G20210A prothrombin gene mutation in Northwestern Greece is 2.7% (95% CI: 0.8% to 4.4%) with an allele frequency of 1.3% (95% CI: 0.4% to 2.3%). CONCLUSION: The G20210A mutation of the prothrombin gene is associated with VTE in the Caucasian residents of this geographic region.


Subject(s)
Mutation , Prothrombin/genetics , Venous Thrombosis/genetics , Case-Control Studies , Female , Genotype , Greece/epidemiology , Humans , Male , Middle Aged , Polymerase Chain Reaction , Prevalence , Risk Factors , Venous Thrombosis/epidemiology , White People/genetics
2.
Int Angiol ; 21(3): 268-71, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12384649

ABSTRACT

BACKGROUND: Hyperhomocysteinemia has been associated with venous thrombosis. Under known and unknown conditions the C677T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene is accompanied by elevated levels of homocysteine. However, the relationship of this mutation with venous thromboembolism (VTE) remains controversial. The purpose of this study was to evaluate the association of the MTHFR mutation with VTE. METHODS: The presence of the C677T mutation in the MTHFR gene was investigated in a population of 176 consecutive patients with a history of venous thromboembolism and in a control group of 300 healthy subjects, using DNA analysis. RESULTS: The prevalence of homozygosity in the patient group was 13.6% and in healthy subjects 10%. The odds ratio for venous thromboembolism in the presence of the homozygous genotype (677TT) was 1.4 (95% confidence interval (C.I.), 0.8 to 2.5), which was not statistically significant. CONCLUSIONS: Homozygosity for the T677 allele of the MTHFR gene, although slightly more prevalent in patients compared to controls, has not been found in association with venous thromboembolism.


Subject(s)
Hyperhomocysteinemia/genetics , Mutation/genetics , Oxidoreductases/genetics , Thromboembolism/genetics , Venous Thrombosis/genetics , 5,10-Methylenetetrahydrofolate Reductase (FADH2) , Adult , DNA Mutational Analysis , Gene Frequency/genetics , Genetic Predisposition to Disease/genetics , Greece , Homozygote , Humans , Hyperhomocysteinemia/complications , Methylenetetrahydrofolate Reductase (NADPH2) , Odds Ratio , Polymorphism, Genetic/genetics , Thromboembolism/etiology , Venous Thrombosis/etiology
3.
Eur J Surg ; 167(2): 106-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11266248

ABSTRACT

OBJECTIVE: To present our experience of mesenteric injuries after blunt abdominal trauma. DESIGN: Retrospective study. SETTING: University hospital, Greece. SUBJECTS: 31 patients with mesenteric injuries out of 333 who required operations for blunt abdominal trauma between March 1978 and March 1998. 21 were diagnosed within 6 hours (median 160 min, early group) and in 10 the diagnosis was delayed (median 21 hours, range 15 hours-7 days, delayed group). INTERVENTIONS: Emergency laparotomy. MAIN OUTCOME MEASURES: Mortality, morbidity, and hospital stay. RESULTS: There were no deaths. The diagnosis was confirmed by diagnostic peritoneal lavage in 17/21 patients in the early group whereas 7/10 in the delayed group were diagnosed by clinical examination alone. Most of the injuries (n = 23) were caused by road traffic accidents. 30 patients had injured the small bowel mesentery and 4 the large bowel mesentery. 25 of the 31 patients had associated injuries. There were no complications in the early group, compared with 6 wound infections and 1 case of small bowel obstruction in the delayed group (p < 0.0001). Median hospital stay in the early group was 11 days (range 3-24) compared with 23 days (range 10-61) in the delayed group (p = 0.004). CONCLUSION: Because delay in diagnosis is significantly associated with morbidity and duration of hospital stay we recommend that all patients admitted with blunt abdominal trauma should have a diagnostic peritoneal lavage as soon as possible


Subject(s)
Abdominal Injuries/diagnosis , Mesentery/injuries , Peritoneal Diseases/diagnosis , Peritoneal Diseases/epidemiology , Wounds, Nonpenetrating/diagnosis , Abdominal Injuries/epidemiology , Abdominal Injuries/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Comorbidity , Emergency Treatment/methods , Female , Follow-Up Studies , Greece/epidemiology , Humans , Incidence , Injury Severity Score , Laparotomy/methods , Male , Mesentery/surgery , Middle Aged , Peritoneal Diseases/surgery , Probability , Risk Assessment , Time Factors , Treatment Outcome , Wounds, Nonpenetrating/epidemiology , Wounds, Nonpenetrating/surgery
4.
Int Angiol ; 19(4): 314-8, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11305729

ABSTRACT

BACKGROUND: Many predisposing factors have been associated with the development of venous thromboembolism. Recently, Factor V Leiden has been described as a common genetic risk factor. The geographic distribution of this genetic abnormality in the general population greatly varies. The prevalence of the Factor V Leiden mutation in Europe is high, particularly in Greece, where according to some authors it is especially high. The purpose of this study was to estimate the prevalence of the Factor V Leiden mutation in patients presenting with at least one episode of venous thromboembolism and to compare it with that of the general population. METHODS: Blood samples were drawn from 388 subjects. 240 healthy blood donors (controls) and 148 unselected patients with a history of one or more episodes of venous thrombosis. DNA analysis was performed using the polymerase chain reaction to amplify the factor V gene exon 10, and to detect the Factor V Leiden point mutation. RESULTS: DNA analysis revealed Factor V Leiden mutations in eight (3.3%) control subjects (seven heterozygous and one homozygous) and in twenty-four (16.2%) patients, (twenty-two heterozygous and two homozygous). The difference between the two groups is statistically significant (p<0.0001; chi2 test). CONCLUSIONS: The prevalence of the Factor V Leiden mutation in the general population of North-Western Greece is 3.3%, which is within the same range as that reported for other European countries. The Factor V Leiden mutation is one of the most important predisposing genetic factors in the development of venous thrombosis and was present in 16.2% of our patients.


Subject(s)
Factor V/analysis , Thromboembolism/etiology , Factor V/genetics , Greece/epidemiology , Heterozygote , Homozygote , Humans , Point Mutation , Polymerase Chain Reaction , Prevalence , Risk Factors , Thromboembolism/epidemiology , Thromboembolism/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...